U of A researchers are harnessing AI to analyze patients’ own cells to create islet cells for transplant
University of Alberta researchers are harnessing the power of artificial intelligence to find a safer, more personalized source of islet cells to treat Type 1 diabetes. The research project, a collaboration between the departments of surgery and computing science, aims to use AI to analyze images to speed up the process and reduce the need for human decision-making…
University of Alberta research highlights potential pathway for new treatments for neurodegenerative diseases
Scientists at the University of Alberta have identified a mechanism for a protein that decreases the chance of developing Alzheimer’s disease – a discovery that highlights a new potential avenue for developing therapeutic treatments. The protein, called CD33, is known for its connection to Alzheimer’s disease susceptibility, but its exact role was unclear until now.…
U of A pharmacy researcher looks for ways to correct a common but often hidden type of diabetes-related heart failure
A University of Alberta laboratory has uncovered a new approach to preventing heart failure in people with Type 2 diabetes, according to research findings published recently in the journal Cell Reports. “We know people with diabetes take drugs for years to control their blood sugars, but the drugs don’t cure their diabetes,” said lead author John Ussher, associate…
U of A pharmacy researcher looks for ways to correct a common but often hidden type of diabetes-related heart failure
A University of Alberta laboratory has uncovered a new approach to preventing heart failure in people with Type 2 diabetes, according to research findings published recently in the journal Cell Reports. “We know people with diabetes take drugs for years to control their blood sugars, but the drugs don’t cure their diabetes,” said lead author John Ussher, associate…
A serious blow to our delusion we are better than Americans
When it comes to health care, Canadians only seem to care about one thing: Are we better than the United States? As long as we “beat” the U.S., we remain smug about our performance, although this attitude can be hard to square with the tens of thousands of Canadians who get quick access to top-level…
The claim that merging Ontario’s government-run and Catholic school systems will save “an estimated $1.6 billion a year” is blarney
In terms of cultural insensitivity, the latest call for ending Ontario’s Catholic school funding wins the shamrock, coming, as it did, on St. Patrick’s Day. But if we overlook that faux pas, we still have to consider the pot of gold that would be saved by absorbing Catholic schools into the government-run system. Or do…
Innovative research could provide a supply of renewable fuel
A potentially huge industrial project to create jet fuel from biowaste has received a $2.89-million funding boost from Natural Resources Canada. The investment, which includes $1.99 million in direct funding and $900,000 in in-kind contributions, will go toward setting up an advanced fuel-testing suite in lead researcher David Bressler’s lab and will also support the work of several…
Researchers are now looking to develop a drug that will boost existing statin drugs to prevent heart disease
A team of researchers at the University of Alberta has uncovered a long-sought link in the battle to control cholesterol and heart disease. The protein that interferes with low-density lipoprotein (LDL) receptors that clear ‘bad’ cholesterol from the blood was identified in findings recently published in Nature Communications by Dawei Zhang, associate professor of pediatrics in the Faculty…
Building on game-changing breast cancer trials, TRIO now testing drugs for breast, lung, ovarian, liver and gastrointestinal cancer
A not-for-profit research group with University of Alberta roots is quietly taking its place in the major leagues of global cancer drug testing. When promising new cancer treatments are ready for trial in humans, researchers from around the world turn to Edmonton-based TRIO (Translational Research in Oncology) to run their clinical trials. “It may seem like…
A fast-growing Edmonton startup company that’s a new player in the cellular agriculture sector recently received US$2.2 million from three U.S. venture capital firms and a number of private investors. Future Fields, which was incorporated in 2018, was founded by two University of Alberta graduates and a former U of A employee. All but two…